FDA
PulseAugur coverage of FDA — every cluster mentioning FDA across labs, papers, and developer communities, ranked by signal.
-
FDA Commissioner Marty Makary resigns after turbulent tenure
FDA Commissioner Dr. Marty Makary is resigning after a turbulent 13-month tenure marked by significant organizational upheaval and controversies. His leadership faced criticism from various groups, including health indu…
-
US debates AI policy, FDA advances AI in clinical trials
The US is experiencing a policy divide regarding artificial intelligence, with the FDA actively promoting AI for clinical trials. Meanwhile, discussions are ongoing about access to frontier AI models, highlighting a bro…
-
Open-source tool grants AI full access to pharma R&D data
An open-source project called drug-pipeline-mcp has been released, offering AI agents comprehensive access to pharmaceutical R&D data. This tool aggregates information on clinical trials, FDA/EMA approvals, safety repor…
-
WHOOP raises $575M at $10.1B valuation, eyes health platform pivot
WHOOP, a company known for its fitness wearables, has secured $575 million in Series G funding at a $10.1 billion valuation. This funding round, which included strategic investments from healthcare giants Abbott and May…
-
AI/ML studies surge in high-income countries, focus on neoplasms
A recent analysis of AI/ML studies conducted between 2010 and 2023 reveals a significant growth trend, particularly in high-income nations. Out of 3,106 studies examined, a notable portion were FDA-regulated (7.6%) and …